Shea J. Andrews

Assistant Professor at the University of California, San Francisco

prof_pic.jpg

San Francisco, CA

I am a genetic epidemiologist and Assistant Professor of Psychiatry and Behavioral Sciences at the University of California, San Francisco. My research investigates how genetic, environmental, and social determinants of health interact to shape Alzheimer’s disease pathogenesis, with the goal of developing predictive models that support personalized approaches to dementia prevention. Because persistent disparities in Alzheimer’s disease disproportionately affect underrepresented populations, my work places particular emphasis on racial and ethnic differences in disease risk, biomarkers, and health outcomes.

For more than a decade, I have applied genetic epidemiology to large, deeply phenotyped cohorts to clarify the causal pathways linking genetic and environmental risk factors to Alzheimer’s disease. My interdisciplinary research integrates longitudinal cohort data with epidemiologic frameworks to characterize how modifiable risk factors influence clinical progression, biomarker trajectories, and cognitive decline. In parallel, I develop computational workflows for statistical genetics approaches—including genome-wide association studies, genetic correlation, polygenic risk scoring, and Mendelian randomization—to define how genetic variation contributes to disease risk and how those effects are modified by environmental exposures. Together, this work aims to move dementia research beyond population-average risk estimates toward prevention strategies that are earlier, more precise, and more equitable.

news

Aug 13, 2026 Thrilled to receive an Alzheimer’s Association Research Grant Award (AARGA) for “Gene-Environment Interactions for Personalized Dementia Risk Assessment”! This project will examine how Alzheimer’s disease polygenic and clinical risk scores interact to influence biomarkers of disease pathology and clinical progression.
Aug 12, 2026 Our new review, led by Paulina Tolosa-Tort, is now published in npj Dementia! “Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments” outlines how integrating genetic and environmental risk factors could support earlier, more personalized, and more equitable dementia prevention.
Jul 28, 2026 Congratulations to Meri Okorie on the publication of the first two papers from her PhD! In Alzheimer’s & Dementia, Meri and colleagues show how cross-ancestry polygenic risk scores can improve Alzheimer’s disease risk prediction in multiethnic cohorts and how dementia polyexposure scores relate to Alzheimer’s disease endophenotypes in a diverse population.
Apr 06, 2026 Excited to share our new JAMA Neurology Viewpoint, “Advancing Precision Dementia Care With Genetic-Exposome Risk Assessment”, co-authored with Kristine Yaffe! We outline how integrating genetic and exposome risk could support earlier, more personalized approaches to dementia prevention.
Dec 18, 2025 Excited to receive a UCSF Resource Allocation Program award for “Validation and Co-design of a Genomic-Exposome Dementia Risk Assessment”! This project will evaluate the clinical utility of integrated genetic-exposome risk reports for dementia and co-develop patient-facing reports with community members and clinical stakeholders.